Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: etoh cirrhosis and hcc now s/p orthotopic liver transplant major surgical or invasive procedure: : orthotopic liver transplant : ercp history of present illness: 62 y.o. male with etoh cirrhosis/hcc with diuretic-resistant ascites despite placement of a tips shunt and resultant significant hydrocele and possible inguinal hernia. he is requiring paracentesis approximately every 7 to 10 days. last tap 2 weeks ago and was scheduled for a tap today at . past medical history: 1. alcohol-related cirrhosis status post tips placement requiring dilatation 2. upper gi bleeding in . patient was treated at an outside hospital and it is unclear whether his upper gi bleed was secondary to esophageal varices or peptic ulcer disease. 3. coronary artery disease status post angioplasty in the . 4. diabetes mellitus type 2 diagnosed in . hemoglobin a1c was 6.3 5. umbilical hernia status post repair 6. right knee surgery 7. depression 8. hcc, growth 2.5x2.5cm confirmed on at the dome of the liver 9. recurrent recent paracentesis due to refractory ascites social history: married with two adult sons. formerly worked as a vice president of a trucking company. drank from the age of 20 until . he never smoked. denies iv drug use. family history: father and brother died of mi at the age of 52. his mother and sister have diabetes. physical exam: 98.3 59 123/72 20 99%ra 5'8", wt 104.8kg a&o x3, nervous, wife present anicteric sclerae, mmm, pharynx wnl, upper dentures neck: no lad, no tm, 2+ bilat carotids without bruits luns: clear cor: rrr, no murmur abd: large/ascites/tense, ventral hernia obvious with head to chin tuck, nt back: r flank lipoma, no cvat tenderness gu: large right hydrocele vasc: 1+ femoral pulses, no bruits ext: trace ankle edema, 2+ dps, no cyanosis neuro: a&o x3, no asterixis/flap, toes down bilat. strength 5/5 bilaterally & equal, skin: erythema pertinent results: on admission: wbc-5.3 rbc-3.27* hgb-10.5* hct-29.8* mcv-91 mch-32.1* mchc-35.3* rdw-14.4 plt ct-156 pt-13.6* ptt-31.7 inr(pt)-1.2* fibrino-486* glucose-153* urean-21* creat-1.7* na-135 k-4.1 cl-102 hco3-24 angap-13 alt-25 ast-43* alkphos-127* amylase-50 totbili-1.6* lipase-44 on discharge wbc-7.7 rbc-2.74* hgb-8.4* hct-24.3* mcv-89 mch-30.9 mchc-34.7 rdw-17.3* plt ct-182 fibrino-271 glucose-111* urean-28* creat-1.8* na-134 k-4.5 cl-104 hco3-22 angap-13 alt-55* ast-22 alkphos-171* amylase-84 totbili-0.8 lipase-114* albumin-2.4* calcium-7.6* phos-2.9 mg-1.9 iron studies: brief hospital course: 62 y/o male with hepatitis c virus cirrhosis and hepatocellular carcinoma is admitted for orthotopic (piggyback) donor after cardiac death (dcd) liver transplant, portal vein-portal vein anastomosis, branch patch (recipient) to celiac patch (donor), common bile duct to common bile duct anastomosis (no t tube) with dr . please see the operative note for surgical details. in addition it should be noted that this is a dcd donor who also was htlv1 and htlv2 serologically positive. prior to surgery this was discussed in detail with dr. in infectious disease and dr. in hepatology. it was determined that the risk of continued progression of his hepatocellular carcinoma and risk of complications and death from his end-stage liver disease was greater than the risk of transmission and the development of disease related to the htlv1 and htlv2 positivity. this was discussed with mr. and mrs. in great detail and informed consent was given. at the time of exploration the patient had approximately 12 liters of ascites that was cloudy and appeared chylous. it did not smell or appear grossly infected. there was no fibrin in the peritoneal cavity and no inflammation suggestive of peritonitis. the fluid was sent for gram stain which returned 1+ polys. cultures were sent which were returned as no growth.he was given vancomycin and zosyn in addition to his preoperative unasyn and in addition received routine induction immunosuppression. he had a small cirrhotic liver with normal anatomy. there was a tumor in theright lobe of the liver, but no evidence of any extrahepatic spread. the donor liver had a replaced left hepatic artery. patient was transferred to the sicu following surgery. he was extubated on pod 2, and subsequently transferred the same day. seen by for blood glucose management. he was managing glucose at home prior to surgery with diet but will be discharged home on lantus and a humalog sliding scale. patient and wife received teaching and meds/syringes/supplies were ordered. on pod 6 the patient suffered a hypotensive episode with tachycardia that appeared to be afib on telemetry. he denied chest pain, sob or palpitations. he received a ns bolus for bp of 80/p. cardiology was consulted. enzymes were cycled (normal, metoprolol was continued. an echo was performed showing an ef of 35%. in addition findings included comparison with the prior study (images reviewed) of , showing the regional left ventricular systolic dysfunction is new and c/w interim ischemia/infarction (mid-lad distribution). no anticoagulation ws recommended, metoprolol was increased to 25 . on pod 4 the medial drain started with more output and a drain bili was sent with a result of 7.7. a ct was done showing no drainable collections. after the patient fall he had an u/s of the liver done to evaluate blood flow which was normal. this output was followed for several days, and output was replaced with albumin for each liter of output. when no relief of drainage, patient was sent for an ercp on (pod 9) cholangiogram showed leak of contrast at the anastomotic site of the and native bile duct and a 9cm by 10f cotton biliary stent was placed successfully across the anastomotic leak site. patient did have post ercp pancreatitis, which was treated with continued clears for an additional day. by pod 11 he was tolerating regular diet and the amylase and lipase normalized. on pod 12 (day of discharge) the final drain was removed and suture placed. he will go home with vna for help with medications and blood sugar management as this is a new therapy for him. medications on admission: celexa 40', furosemide 80', spironolactone 25', flomax 0.4', oxycodone 5'hs, lactulose prn, discharge medications: 1. fluconazole 200 mg tablet sig: two (2) tablet po q24h (every 24 hours). 2. prednisone 5 mg tablet sig: four (4) tablet po once a day for 3 days: follow prednisone taper per transplant clinic guidelines. 3. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day): continue as long as taking pain medication and as needed. disp:*60 capsule(s)* refills:*2* 4. trimethoprim-sulfamethoxazole 80-400 mg tablet sig: one (1) tablet po daily (daily). 5. valganciclovir 450 mg tablet sig: one (1) tablet po daily (daily). 6. mycophenolate mofetil 500 mg tablet sig: two (2) tablet po bid (2 times a day). 7. citalopram 20 mg tablet sig: two (2) tablet po daily (daily). 8. senna 8.6 mg tablet sig: one (1) tablet po bid prn as needed for constipation. disp:*60 tablet(s)* refills:*0* 9. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 10. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 11. oxycodone 5 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed. disp:*60 tablet(s)* refills:*0* 12. tamsulosin 0.4 mg capsule, sust. release 24 hr sig: one (1) capsule, sust. release 24 hr po hs (at bedtime). 13. insulin glargine 100 unit/ml solution sig: twenty (20) units subcutaneous at bedtime: then continue sliding scale humalog. 14. tacrolimus 1 mg capsule sig: two (2) capsule po twice a day. 15. tacrolimus 0.5 mg capsule sig: one (1) capsule po twice a day: total 2.5 mg . discharge disposition: home with service facility: home care services discharge diagnosis: etoh cirrhosis and hcc now s/p liver transplant discharge condition: good discharge instructions: call the transplant office at if you experience any of the following symptoms: fever > 101, chills, nausea, vomiting, diarrhea, inability to eat, or inability to take or keep down medications. monitor for pain over the incision site or liver, yellowing of the skin or eyes, an increase in abdominal girth. monitor incision for redness, drainage or bleeding. do not drive if you are taking narcotics. take your medications exactly as directed. no heavy lifting you may shower, pat incision dry have labs drawn every monday and thursday and have them faxed to . cbc, chem 10, ast, alt, alk phos, albumin, t bili and trough prograf level followup instructions: please call for appointment with dr on wednesday md, procedure: endoscopic insertion of stent (tube) into bile duct other transplant of liver transfusion of packed cells transfusion of other serum transfusion of coagulation factors other operations on lacrimal gland transplant from cadaver diagnoses: congestive heart failure, unspecified alcoholic cirrhosis of liver cardiac complications, not elsewhere classified atrial fibrillation diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes percutaneous transluminal coronary angioplasty status systolic heart failure, unspecified other specified disorders of biliary tract other ascites malignant neoplasm of liver, primary acute pancreatitis inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) hydrocele, unspecified 

Answer: The patient is high likely exposed to